Clinical trials
Recruiting Leukemia trials in Taiwan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
4 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2022 | 1 |
| 2023 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 4 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 1 |
| Dren Bio | 1 |
| Kura Oncology, Inc. | 1 |
| National Defense Medical University, Taiwan | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia | 4 |
| Leukemia, Myeloid, Acute | 2 |
| Brain Neoplasms | 1 |
| Burkitt Lymphoma | 1 |
| Enteropathy-Associated T-Cell Lymphoma | 1 |
| Hematologic Neoplasms | 1 |
| Leukemia, Large Granular Lymphocytic | 1 |
| Lymphoma | 1 |
| Lymphoma, Extranodal NK-T-Cell | 1 |
| Neoplasms | 1 |
Trials
Showing 1 to 4 of 4. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.